Weight loss medication overview
Part of treatment Medical weight loss
The Weight loss medication
The medications listed below are part of the Medical Weight Loss treatment and are offered only as part of this treatment. All medication is prescription required. If you are eligible for treatment, the medication will be prescribed by our doctor and dispensed by our affiliated pharmacist.
Saxenda
Saxenda (substance name Liraglutide) is an injectable drug used to help obese adults lose and maintain weight. Developed by the pharmaceutical company Novo Nordisk, Saxenda is available by prescription only. Read more about Saxenda…
| Administration: | Daily lancing pen |
| Active ingredient: | Liraglutide |
| Target population: | Overweight: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite, increases feelings of satiety and improves sugar metabolism. |
| Side effects: | The most common side effects are nausea, vomiting, diarrhea, constipation, headache and fatigue. |
| Package insert: | Download Saxenda’s package insert. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.
Starter (low dosage) program:
Extending the program:
Programs:
|
Ozempic
Ozempic (semaglutide) is an injectable drug used to treat type 2 diabetes. It belongs to a class of drugs called glucagon-like peptide-1 (GLP-1) receptor agonists, which act on the body’s natural GLP-1 receptors to help regulate blood sugar levels. Read more about Ozempic…
| Administration: | Weekly lancing pen |
| Active ingredient: | Semaglutide |
| Target population: | Diabetes mellitus type 2 |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite, increases feelings of satiety and improves sugar metabolism. |
| Side effects: | The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the Ozempic package insert. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.
Starter (low dose) program:
Extend program:
Programs:
|
Wegovy
Wegovy contains the active ingredient Semaglutide, an analog of GLP-1, a body’s own gut hormone that regulates the sense of hunger and satiety. Wegovy can be used as adjunctive therapy for obese or overweight adult patients who have at least one health condition related to their obesity, such as type 2 diabetes, high blood pressure or dyslipidemia (high cholesterol). Read more about Wegovy…
| Administration: | Weekly lancing pen |
| Active ingredient: | Semaglutide |
| Target population: | Overweight: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download Wegovy’s package insert. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.
Starter (low dose) program:
Extend program:
Programs:
|
Mounjaro
Mounjaro is a brand name for a drug known as Tirzepatide. It is used to treat type 2 diabetes and for weight management. Mounjaro has an effect on the sense of hunger and satiety. It works by lowering blood sugar levels and improving insulin production in the body. This drug also has beneficial effects on weight loss. Read more about Mounjaro…
| Administration: | Weekly injection |
| Active ingredient: | Tirzepatide |
| Target population: | Diabetes mellitus type 2 & Overweight: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the package insert for Mounjaro. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.Prices depend on the duration of the program and the dosage of the medication.
Starter (low dosage) program:
Extending the program: Kwikpen:
Programs:
|
Rybelsus
Rybelsus is a drug used to treat type 2 diabetes. Rybelsus works by stimulating insulin production and reducing the amount of glucose produced by the liver. This helps keep blood sugar levels within a healthy range and can reduce risk factors for diabetes such as heart disease, stroke and kidney damage. Read more about Rybelsus…
| Administration: | Pill form, 1x daily |
| Active ingredient: | Semaglutide |
| Target population: | Diabetes mellitus type 2 |
| Explanation of operation: | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases feelings of satiety |
| Side effects: | The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue. |
| Package insert: | Download the package insert for Rybelsus. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.
Starter (low dosage) program:
Extending the program:
Programs:
|
Mysimba
Mysimba (substance names: naltrexone and bupropion) is an oral medication used to help obese adults lose and maintain weight. This drug acts on areas of the brain involved in the regulation of food intake and energy consumption, thus affecting specific cravings. Read more about Mysimba…
| Administration: | Pill form, 2x daily |
| Active ingredient: | Naltrexone / Bupropion |
| Target population: | Overweight: BMI≥30, or BMI≥27 with a weight-related condition |
| Explanation of effect: | The drug acts on the craving system in the body and prevents impulse eating. |
| Side effects: | The most common side effects are dizziness, headache, palpitations, fatigue, insomnia. |
| Package insert: | Download the package insert for Mysimba. |
| Price: | The medication is not available separately, but only as part of the medical weight loss treatment.
Starter (low dosage) program:
Extending the program:
Programs:
|
